Diabetes, Vol 41, Issue 2 123-129, Copyright © 1992 by American Diabetes Association

ARTICLES

HLA and insulin-dependent diabetes. A protective perspective

MJ Sheehy
Research Department, American Red Cross Blood Services, Madison, WI 53705.

This article presents a model for the HLA effect in insulin-dependent diabetes mellitus (IDDM) that is almost the mirror image of a model suggested by Nepom. In the Nepom model, the products of certain HLA alleles are associated with IDDM because they bind and present a specific peptide or peptides so as to induce an immune response to pancreatic beta-cells; certain other alleles can protect against IDDM if they compete strongly for binding of the diabetogenic peptide. My model focuses instead on the failure of the immune system to maintain tolerance to pancreatic beta-cells. I suggest that the HLA alleles negatively associated with IDDM (e.g., DR2 and DQw1) produce products with high affinity for certain beta-cell peptide or peptides needed to establish and maintain tolerance to beta-cells, whereas the alleles that are common in IDDM (e.g., DR3, DR4, and DQw8) produce products that have low affinity for the tolerogenic peptide or peptides or that bind the peptide or peptides in the wrong orientation or configuration for establishing tolerance. I also discuss the multiplicity of HLA loci, alleles, and amino acids contributing to IDDM and the fact that the associations of specific loci, alleles, and even genotypes with IDDM depend not only on their intrinsic properties but also on various population parameters.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. P. Marron, R. T. Graser, H. D. Chapman, and D. V. Serreze Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice PNAS, October 15, 2002; 99(21): 13753 - 13758. [Abstract] [Full Text] [PDF]

				F. Cucca, R. Lampis, M. Congia, E. Angius, S. Nutland, S. C. Bain, A. H. Barnett, and J. A. Todd A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins Hum. Mol. Genet., September 1, 2001; 10(19): 2025 - 2037. [Abstract] [Full Text] [PDF]

				R. T. Graser, T. P. DiLorenzo, F. Wang, G. J. Christianson, H. D. Chapman, D. C. Roopenian, S. G. Nathenson, and D. V. Serreze Identification of a CD8 T Cell That Can Independently Mediate Autoimmune Diabetes Development in the Complete Absence of CD4 T Cell Helper Functions J. Immunol., April 1, 2000; 164(7): 3913 - 3918. [Abstract] [Full Text] [PDF]

				D. J. Becker, R. E. LaPorte, I. Libman, M. Pietropaolo, and H.-M. Dosch Prevention of Type 1 Diabetes: Is Now the Time? J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 498 - 506. [Full Text]

				A. Pugliese, E. Kawasaki, M. Zeller, L. Yu, S. Babu, M. Solimena, C. T. Moraes, M. Pietropaolo, R. P. Friday, M. Trucco, et al. Sequence Analysis of the Diabetes-Protective Human Leukocyte Antigen-DQB10602 Allele in Unaffected, Islet Cell Antibody-Positive First Degree Relatives and in Rare Patients with Type 1 Diabetes J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1722 - 1728. [Abstract] [Full Text]

				L. S. Wicker Major Histocompatibility Complex-linked Control of Autoimmunity J. Exp. Med., October 6, 1997; 186(7): 973 - 975. [Full Text] [PDF]

				M. A. Atkinson and N. K. Maclaren The Pathogenesis of Insulin-Dependent Diabetes Mellitus N. Engl. J. Med., November 24, 1994; 331(21): 1428 - 1436. [Full Text]